Endolymphatic sac tumours: Surgical management

Journal of Otolaryngology

Volumn 35, Issue 6, 2006, Pages 387-394

  Schipper, Jörg ^a   Maier, Wolfgang ^a   Rosahl, Steffen K ^a   Van Velthoven, Vera ^a   Berlis, Ansgar ^a   Boedeker, Carsten Christof ^a   Laszig, Roland ^a   Teszler, Christian Barna ^a,b   Ridder, Gerd Jürgen ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Ear neoplasms; Endolymphatic sac; Germline mutation; Labyrinth diseases; Temporal bone pathology; Von Hippel Lindau disease

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; DURA MATER; ENDOLYMPHATIC SAC; ENDOLYMPHATIC SAC TUMOR; FACIAL NERVE; FEMALE; FOLLOW UP; HUMAN; MALE; NEUROIMAGING; PERCEPTION DEAFNESS; PRIORITY JOURNAL; TEMPORAL BONE; TUMOR RECURRENCE; VESTIBULAR DISORDER;

ADULT; DIAGNOSTIC IMAGING; EAR NEOPLASMS; ENDOLYMPHATIC SAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OTOLOGIC SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846118291     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2006.0082     Document Type: Article

References (63)

1. Hassard AD, Bourdreau SF, Cron CC. Adenoma of the endolymphatic sac. J Otolaryngol 1984;13:213-6.
2. Roncaroli F, Giangaspero F, Piana S, et al. Low-grade adenocarcinoma of endolymphatic sac mimicking jugular paraganglioma at clinical and neuroradiological examination. Clin Neuropathol 1997;16:243-6.
3. Eby TL, Makek MS, Fisch U. Adenomas of the temporal bone. Ann Otol Rhinol Laryngol 1988;97:605-12.
4. Gaffey NJ, Mills SE, Fechner RE, et al. Aggressive papillary middle ear tumour. A clinicopathologic entity distinct from middle ear adenoma. Am Surg Pathol 1988;12:790-7.
5. Delisle MB, Uro E, Rouquette E, et al. Papillary neoplasm of the endolymphatic sac in a patient with von Hippel-Lindau disease. J Clin Pathol 1994;47:959-61.
6. Harrison K, Cronin J, Greenwood N. Ceruminous adenocarcinoma in the middle ear. J Laryngol Otol 1974;88:363.
7. Pollak A, Bohmer A, Spycher M, Fisch U. Are papillary adenomas endolymphatic sac tumours? Ann Otol Rhinol Laryngol 1995;94: 613-9.
8. Ho VT, Rao VM, Doan HT, Mikaelian DO. Low grade adenocarcinoma of probable endolymphatic sac origin: CT and MR appearance. AJNR Am J Neuroradiol 1996;17:168-70.
9. Folker RJ, Meyerhoff WL, Rushing EJ. Aggressive papillary adenoma of the cerebellopontine angle: case report of an endolymphatic sac tumor. Am J Otolaryngol 1997;18:135-9.
10. Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin: a clinicopathologic study of 20 cases. Cancer 1989;64:2292-302.
11. Benecke JE, Noel FL, Carberry JN, et al. Adenomatous tumours of the middle ear and mastoid. Am J Otol 1990;11:20-6.
12. Li JC, Brackmann DE, Lo WWM, et al. Reclassification of aggressive adenomatous mastoid neoplasms as endolymphatic sac tumors. Laryngoscope 1993;103:1342-8.
13. Jones SEM, Yung MW, Orell JM, Norris A. Adenoma of the middle ear: a report of two cases. J Laryngol Otol 2001;115:216-9.
14. Reijneveld J, Hanlo P, Groenewoud G, et al. Endolymphatic sac tumours: a case report and review of the literature. Surg Neurol 1997;48:368-73.
15. Roche P, Dufour H, Figarella-Branger D, Pellet W. Endolymphatic sac tumours: report of three cases. Neurosurgery 1998;42:927-32.
16. Ferreira MA, Feiz-Erfan I, Zabramski JM, et al. Endolymphatic sac tumor: unique features of two cases and review of the literature. Acta Neurochir (Wien) 2002;144:1047-53.
17. Kempermann G, Neumann HP, Scheremet R, et al. Deafness due to bilateral endolymphatic sac tumours in a case of von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 1996;61:318-20.
18. Panchwagh J, Goel A, Shenoy A. Bilateral endolymphatic papillary carcinoma. Br J Neurosurg 1999;13:79-81.
19. Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991;337:1052-4.
20. Neumann HP, Berger DP, Sigmund G, et al. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 1993;329:1531-8.
21. Neumann HPH. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 1994; 330:1091-2.
22. Neumann HPH, Eng C, Mulligan LM, et al. Consequences of direct genetic testing for germline mutations in the clinical management of families with mutiple endocrine neoplasia type II. JAMA 1995;274:1149-51.
23. Maher ER, Kaelin WG Jr. Von Hippel-Lindau disease. Medicine (Baltimore) 1997;76:381-91.
24. Seizinger BR, Rouleau GA, Ozelius LJ, et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988;332:268-9.
25. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260: 1317-32.
26. Kuzmin I, Duh FM, Latif F, et al. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene 1995;10:2185-94.
27. Blamires TI, Friedman I, Moffat DA. Von Hippel-Lindau disease associated with an invasive choroid plexus tumour presenting as a middle ear mass. J Laryngol Otol 1992;106:429-35.
28. Megerian CA, McKenna MJ, Nuss RC, et al. Endolymphatic sac tumours' histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease. Laryngoscope 1995; 105:801-8.
29. Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumours. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 1997;277:1461-6.
30. Tibbs RE Jr, Bowles AP, Jr, Raila FA, et al. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report. Neurosurgery 1997;40:848-55.
31. Vortmeyer AO, Choo D, Pack SD, et al. Von Hippel-Lindau disease gene alterations associated with endolymphatic sac tumor. J Natl Cancer Inst 1997;89:970-2.
32. Megerian CA, Haynes DS, Poe DS, et al. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome. Otol Neurotol 2002;23:378-87.
33. Gilsbach JM. Hemangioblastomas of the spinal cord and the brainstem: diagnostic and therapeutic features. Neurosurg Rev 1996;19:147-51.
34. Fill WL, Lamiell JM, Polk NO. The radiographic manifestations of von Hippel-Lindau disease. Radiology 1979;133:289-95.
35. Filling-Katz MR, Choyke PL, Patronas NJ, et al. Radiologic screening for von Hippel-Lindau disease: the role of Gd-DTPA enhanced MR imaging of the CNS. J Comput Assist Tomogr 1989; 13:743-55.
36. Choyke PL, Glenn GM, Walther MM, et al. Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 1995;194: 629-42.
37. Luff DA, Simmons M, Malik T, et al. Endolymphatic sac tumours. J Laryngol Otol 2002;116:398-401.
38. Trietel L. Uber das Carcinom des Ohres. Z Ohrenheilk 1898;33: 152-64.
39. Hyams VJ, Michaels L. Benign adenomatous neoplasm (adenoma) of the middle ear. Clin Otolaryngol 1976;1:17-26.
40. von Hippel E. Über eine sehr seltene Erkrankung der Netzhaut. Von Graefes Arch Ophthalmol 1904;59:83-106.
41. Lindau A. Studien über Kleinhirnzysten. Bau, Pathogenese und Beziehungen zur Angiomatosis retinae. Acta Path Microbiol Scand 1926;Suppl 1:1-128.
42. Palmer JM, Coker NJ, Harper RL. Papillary adenoma of the temporal bone in von Hippel-Lindau disease. Otolaryngol Head Neck Surg 1989;100:64-8.
43. Thomas CB, Kveton JF, Poe DS, et al. Aggressive papillary tumour of temporal bone in von Hippel-Lindau disease. Surg Pathol 1993; 5:63-71.
44. Kawahara N, Kume H, Ueki K, et al. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology 1999;53:208-10.
45. Glavac D, Neumann HP, Wittke C, et al. Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet 1996;98: 271-80.
46. Lee KR, Wulfsberg E, Kepes JJ. Some important radiological aspects of the kidney in Hippel-Lindau syndrome: the value of prospective study in an affected family. Radiology 1977;122:649-53.
47. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DANN methylation in renal cell carcinoma. Proc Natl Acad Sci U S A 1995;91:9700-4.
48. Iwai K, Yamanaka K, Kamura T, et al. Identification of the von Hippel-Lindau tumor suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci U S A 1999;96:12436-41.
49. Bradley JF, Collins DL, Schimke NR, et al. Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene. Am J Med Genet 1999;87:163-7.
50. Hasse C. Bemerkungen über die Lymphbahnen des inneren Ohres. Arch Ohrenheilk (Leipzig) 1881;17:188-94.
51. Heffner DK. Are papillary adenomas endolymphatic sac tumors? Ann Otol Rhinol Laryngol 1996;105:251-2.
52. Ahuja A, Gibbons KJ. Endovascular therapy of central nervous system tumors. Neurosurg Clin N Am 1994;5:541-4.
53. Horton JA, Eelkema E, Albright AL. Preoperative embolization of a hemangioblastoma. AJNR Am J Neuroradiol 1989;10:203.
54. Eskridge JM, McAuliffe W, Harris B, et al. Preoperative endovascular embolization of craniospinal hemangioblastomas. AJNR Am J Neuroradiol 1996;17:525-31.
55. Tampieri D, Leblanc R, TerBrugge K. Preoperative embolization of brain and spinal hemangioblastomas. Neurosurgery 1993;33:502-5.
56. Vazquez-Anon V, Botella C, Beltran A, et al. Preoperative embolization of solid cervicomedullary junction hemangioblastomas: report of two cases. Neuroradiology 1997;39:86-9.
57. Page KA, Wayson K, Steinberg GK, Adler JR Jr. Stereotaxic radiosurgical ablation: an alternative treatment for recurrent and multifocal hemangioblastomas. A report of four cases. Surg Neurol 1993;40:424-8.
58. Chandler HC Jr, Friedman WA. Radiosurgical treatment of a hemangioblastoma: case report. Neurosurgery 1994;34:353-5.
59. Chang SD, Meisel JA, Hancock SL, et al. Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 1998;43:28-35.
60. Chakraborti PR, Chakrabarti KB, Doughty D, Plowman PN. Stereotactic multiple arc radiotherapy. IV-Haemangioblastoma. Br J Neurosurg 1997;11:110-5.
61. Patrice SJ, Sneed PK, Flickinger JC, et al. Radiosurgery for hemangioblastoma: results of a multiinstitutional experience. Int J Radiat Oncol Biol Phys 1996;35:493-9.
62. Pan L, Wang EM, Wang BJ, et al. Gamma knife radiosurgery for hemangioblastomas. Stereotact Funct Neurosurg 1998;Suppl 1: 179-86.
63. Neumann HP. Prognosis of von Hippel-Lindau syndrome. Vasa 1987;16:309-11.